Optimal Balloon Catheter Placement During Sonohysterography

May 4, 2014 updated by: Royan Institute

Pain Perception and Side Effects During Sonohysterography With Balloon Catheters: a Randomized Comparative Study of Cervical With Uterine Catheter Placement

Saline infusion sonohysterography and other intrauterine investigations methods may cause uterine cramping, pain and vasovagal reactions. According to few of previous studies the position of catheter placement can affect the magnitude of pain and amount of saline required during the sonohysterography. The purpose of this double blind control trial study is to assess whether the location of the balloon catheter either the uterus or cervix during sonohysterography can affect the magnitude of pain and the rate of vasovagal reaction.

Study Overview

Detailed Description

The proposal of study approved by the investigators institutional review boards and institution's ethical committee, and all participants will sign a written consent before enter to study. A total of 300 infertile women undergoing sonohysterography will be randomized to intrauterine or intracervical balloon catheter placement. The examination is scheduled in the early follicular phase of menstrual cycle, immediately after cessation of menstrual flow and before day 10. After preparation of patient, a 2 lumen 6-French flexible catheter is introduced into the cervical canal and balloon at the catheter tip is placed in the lower uterine segment or 1 cm into cervical canal and inflated with 1 mL of sterile saline solution. Under sonographic guidance, sterile normal saline solution (10-50 mL) is slowly introduced into the cavity until an adequate distention of the uterine cavity is obtained. Three-dimensional ultrasound scanned volumes are recorded. Patients are asked to assess their level of pain at the time of the balloon inflation and deflation using a 10-point visual analog pain scale. Patients are checked for the sign and symptoms of vasovagal reaction during and 30 minutes after procedure. Outcome measures will be assessed based on the intent-to-treat principle.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Infertile patients who will be referred to Royan institute for sonohysterography to evaluate the internal structure of uterine cavity (acquired & congenital abnormalities) are included in this prospective comparative study.

Exclusion Criteria:

  • Exclusion Criteria:

    • Symptoms of active pelvic infection
    • Abnormal uterine bleeding
    • Women with cervical stenosis
    • Women with each lesions which disrupts catheterization such as large myoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: patients with intrauterine balloon catheter placement
In this group, during the procedure of sonohysterography balloon catheter is inflated in the uterine cavity
during the procedure of sonohysterography balloon catheter is inflated in the uterine cavity
ACTIVE_COMPARATOR: patients with intracervical balloon catheter placement
During the procedure of sonohysterography balloon catheter is inflated in the cervical canal
During the procedure of sonohysterography balloon catheter is inflated in the cervical canal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
perceived Pain
Time Frame: during sonohysterography
inflation of the balloon & deflation of the balloon by a 10-point visual analog pain scale
during sonohysterography
Vasovagal reactions
Time Frame: During sonohysterography
Evaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients During procedure .
During sonohysterography
vasovagal reaction
Time Frame: 30 minutes after sonohysterography
Evaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients 30 minutes after procedure .
30 minutes after sonohysterography

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saline volume
Time Frame: during sonohysterography
Evaluation the saline volume that is required for sonohisterography
during sonohysterography
time of procedure
Time Frame: during sonohysterography
Evaluation the total time that is needed for sonohysterography.
during sonohysterography

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Fatemeh Zafarani, MSc, Department of Reproductive Imaging at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine
  • Principal Investigator: Firoozeh Ahmadi, MD, Department of Reproductive Imaging at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (ACTUAL)

September 1, 2013

Study Completion (ACTUAL)

October 1, 2013

Study Registration Dates

First Submitted

August 25, 2013

First Submitted That Met QC Criteria

September 1, 2013

First Posted (ESTIMATE)

September 5, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

May 6, 2014

Last Update Submitted That Met QC Criteria

May 4, 2014

Last Verified

February 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Royan-Emb-016

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on sonohysterography with inflated catheter in uterine cavity

3
Subscribe